Galderma Has Celebrated 30 Years of Restylane
The injectable brand marks three decades of dermatological use with new product approvals and sustainable syringe designs.
Updated on Oct. 6, 2026 in Beauty
Live Poll
Would you consider using injectable aesthetic treatments to manage signs of aging or weight loss?
Galderma has marked the 30th anniversary of its flagship Restylane brand, which stands as the world's first hyaluronic acid injectable. The milestone coincides with recent regulatory approvals for new facial enhancement products and a global rollout of updated, eco-friendly syringe technology.
Why it matters
The brand is expanding its clinical focus to address facial volume loss associated with menopause and medication-driven weight loss. This strategic evolution highlights how long-standing cosmetic treatments are adapting to address changing demographic needs.
The Restylane portfolio is backed by 80 clinical trials and 180 scientific publications. A recent survey indicated an 89% preference rate among practitioners for the brand's newly introduced, 100% recyclable syringe design.
The players
Galderma
Headquartered in Switzerland, this pharmaceutical company specializes in dermatological treatments and skincare products.
The details
Restylane Volyme gained U.S. approval in March 2026 for treating temple hollowing using a dual-layer injection technique, while Restylane Shaype was cleared in the EU for chin enhancement. The updated syringe design aims to reduce clinical waste by 30% through compact, blister-free packaging.
Timeline
March 2026: Restylane Volyme received United States approval.
2026: A new syringe design was approved for use in the EU, US, and Canada.
October 2026: Galderma marked the 30th anniversary of the Restylane brand.
Culture Shift
The industry is increasingly focused on reconciling aesthetic innovation with environmental sustainability through new packaging standards. This move follows the strict certification requirements mandated by the European Union Medical Device Regulation.
Patients may notice new, more sustainable syringe packaging during their next clinical consultation. These design updates are intended to improve ergonomic functionality for practitioners while reducing the environmental footprint of cosmetic procedures.
The takeaway
The longevity of the Restylane brand demonstrates how established medical products can evolve to meet modern demands like sustainability and specific aging concerns. Patients should consult with licensed providers to discuss how these updated treatment options align with their specific needs.
Further reading
Learn more about the latest developments in cosmetic trends in our Beauty section.
More information
For further corporate updates and product information, visit the Galderma official corporate website.
Live Poll
Would you consider using injectable aesthetic treatments to manage signs of aging or weight loss?
